Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E
Department of Nephrology, University of Heidelberg, Germany.
Nephrol Dial Transplant. 1998 Apr;13(4):975-7. doi: 10.1093/ndt/13.4.975.
Ultrasound-guided renal biopsy with an automated spring-loaded biopsy device has become the standard method for kidney biopsy. Information on the success rate and safety of the routine use of this procedure from large series is not available. Such information is of interest for cost benefit considerations and for medicolegal purposes. We performed an audit of this procedure.
From January 1993 to June 1997, 1090 percutaneous renal biopsies were performed in the renal units of Heidelberg (n = 557) and Karlsruhe (n = 533) using a spring-loaded biopsy device (Biopty; Radiplast AB, Uppsala, Sweden). After intensive local disinfection, biopsies were performed under local anaesthesia and direct visualization by ultrasound (Sonolayer SSH-140 A, Toshiba Inc., Japan). A puncturing adaptor was used (model UAGV 009 A, Toshiba, Japan). Of the 1090 biopsies 114 (10.4%) were performed on renal allografts and 976 (89.6%) on orthotopic kidneys. Biopsies were performed only if patients were strictly normotensive (<140/90 mmHg) and had normal coagulation parameters (PT, PTT, factor VIII, thrombocyte count, and bleeding time). All patients had been advised not to take aspirin or non-steroidal antiinflammatory agents for at least 5 days prior biopsy. We analysed (1) yield of diagnostically useful material, and (2) frequency of postbiopsy complications (e.g. macrohaematuria, haematoma, infections, and AV fistula).
Except for one case requiring interventional radiology because of persisting blood loss and three cases requiring blood transfusions, no serious complications were seen in the 1090 consecutive renal biopsies, e.g. death, loss of kidney, life-threatening haemorrhage, or persisting haemodynamically relevant AV fistulae. The frequency of minor haematoma with an extension >2 x 2 cm, but no significant decrease of haemoglobin, was 2.2% (25/1090). Self-limited mild macrohaematuria occurred in 0.8% (9/1090). The incidence of small, haemodynamically irrelevant AV fistulae detected by Doppler ultrasound was 9% (48/533). Sufficient tissue for reliable histopathological diagnosis was obtained in almost all cases (1077/1090 = 98.8%). The median number of glomeruli per biopsy sample was 9 (range 1-37).
If contraindications, especially high blood pressure and abnormal haemostasis, are respected, ultrasound-guided percutaneous renal biopsy with an automated biopsy device is safe. Skilled operators obtain satisfactory amounts of kidney tissue in almost all cases.
使用自动弹簧式活检装置进行超声引导下肾活检已成为肾活检的标准方法。目前尚无来自大量病例系列的关于该常规操作成功率和安全性的信息。此类信息对于成本效益考量和法医学目的而言很有意义。我们对该操作进行了一项审计。
1993年1月至1997年6月期间,在海德堡(n = 557)和卡尔斯鲁厄(n = 533)的肾脏科室,使用弹簧式活检装置(Biopty;Radiplast AB,瑞典乌普萨拉)进行了1090例经皮肾活检。在严格局部消毒后,于局部麻醉及超声直接可视化(日本东芝公司的Sonolayer SSH - 140 A型超声)下进行活检。使用了穿刺适配器(日本东芝公司的UAGV 009 A型)。在这1090例活检中,114例(10.4%)针对肾移植,976例(89.6%)针对原位肾。仅在患者严格血压正常(<140/90 mmHg)且凝血参数正常(PT、PTT、因子VIII、血小板计数及出血时间)时才进行活检。所有患者在活检前至少5天被建议停用阿司匹林或非甾体类抗炎药。我们分析了(1)诊断有用材料的获取量,以及(2)活检后并发症的发生率(如肉眼血尿、血肿、感染及动静脉瘘)。
在这1090例连续肾活检中,除1例因持续失血需介入放射治疗及3例需输血外,未见严重并发症,如死亡、肾丢失、危及生命的出血或持续存在的具有血流动力学意义的动静脉瘘。血肿范围>2×2 cm但血红蛋白无显著下降的轻微血肿发生率为2.2%(25/1090)。自限性轻度肉眼血尿发生率为0.8%(9/1090)。经多普勒超声检测到的血流动力学无意义的小动静脉瘘发生率为9%(48/533)。几乎所有病例(1077/1090 = 98.8%)均获取了足够用于可靠组织病理学诊断的组织。每个活检样本中肾小球的中位数为9个(范围1 - 37个)。
如果遵循禁忌证,尤其是高血压和止血异常,使用自动活检装置进行超声引导下经皮肾活检是安全的。熟练的操作人员在几乎所有病例中都能获取满意量的肾组织。